BRAINXPLORE

Explore our scientific resources

Get our newsletters

Published on the 2 May 2026

Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study

Consult this publication on Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study, in which studies were conducted on our in vitro …

Publications
Published on the 1 September 2025

Publication on Functional discrimination of CSF from Alzheimer’s patients in a brain on chip platform

Publication: Functional discrimination of CSF from Alzheimer’s patients in a brain on chip platform. Sci Rep 15, 29738 (2025). Authors: Miny, L., Rontard, J., Allouche, A. et al. Affiliated: N…

Publications
Published on the 17 July 2025

Publication on NDD’s cellular models – Scientific Reports (Nature)

Consult the publication in which ETAP-LAB was mentioned and acknowledged for our in vitro hippocampal neuron model—challenged with own-manufactured Tau oligomers: "A novel allosteric GCase modulator p…

Publications
Published on the 13 June 2025

POSTER: High-throughput Brain-on-Chip for neurogenerative diseases

Dr Valentin TALLANDIER, in vitro Preclinical Project Leader, presented the team’s research during the MPS World Summit 2025 in Brussels in his poster. Learn more about our high-thoughput capa…

Posters
Published on the 19 May 2025

POSTER: “NEUROINFLAMMATION MODELS OF NEURODEGENERATIVE DISEASES”

Dr Ahmad Allouche, Head of in vitro biology, presented the team’s research* during at Venusberg Neuroinflammation Meeting 2025 in Luxembourg in his poster “NEUROINFLAMMATION MODELS OF NEURODEGENERATIV…

Posters
Published on the 4 April 2025

POSTER: “ADVANCING ALZHEIMER’S DISEASE MODELS FOR PRECLINICAL DRUG TESTING”

Dr Ahmad Allouche, Head of in vitro biology, presented the team's research* during AD/PD 2025 in Vienna in his poster "ADVANCING ALZHEIMER'S DISEASE MODELS FOR PRECLINICAL DRUG TESTING". Learn more…

Posters
Published on the 12 March 2025

Technical Note: High-content imaging of brain-on-chip microfluidic devices using PreciScan intelligent acquisition.

Brain-on-chips (BoC) are innovative tools that simulate complex brain environments, enhancing our understanding of neurodegenerative diseases (NDDs). While a range of BoC platforms have been developed…

Technical notes
Published on the 22 May 2022

The Anxiolytic-like Properties of a Tryptic Hydrolysate of Bovine αs1 Casein Containing α-Casozepine Rely on GABAA Receptor Benzodiazepine Binding Sites but Not the Vagus Nerve

Background A tryptic hydrolysate of bovine αs1-casein (CH) exerts anxiolytic-like properties in many species, including humans. This is mainly related to the presence of α-casozepine (α-CZP), which…

Publications

Discover our scientific resources and browse posters…

Discover our resources